Zolpidem Tartrate Tablet, Extended Release
Product Images NDC 60760-819

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zolpidem Tartrate (NDC 60760-819). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Zolpidem Tartrate (8bb9d44d 6ee5 4174 8d42 52078de66779 01)

FDA Label Image

Im-2 (8bb9d44d 6ee5 4174 8d42 52078de66779 02)

Im-2 (8bb9d44d 6ee5 4174 8d42 52078de66779 02)
This information shows zolpidem plasma concentrations (ng/mL) over time after the administration of 12.5 mg zolpidem tartrate extended-release tablets or 10 mg zolpidem tartrate immediate release. The graph displays concentration levels at different time points ranging from 0 to 8 hours.*
FDA Label Image

819- (Zolpidem 60760 819 30)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.